General and supportive therapy of pulmonary arterial hypertension

被引：8

作者：

Gruenig, E. ^{[1
]}

Benjamin, N. ^{[1
]}

Krueger, U. ^{[2
]}

Kaemmerer, H. ^{[3
]}

Harutyunova, S. ^{[1
]}

Olsson, K. M. ^{[4
,5
]}

Ulrich, S. ^{[6
]}

Gerhardt, F. ^{[7
]}

Neurohr, C. ^{[8
]}

Sablotzki, A. ^{[9
]}

Halank, M. ^{[10
]}

Kabitz, H. -J. ^{[11
]}

Thimm, G. ^{[12
]}

Fliegel, K. -G. ^{[12
]}

Klose, H. ^{[13
]}

机构：

[1] Univ Klinikum Heidelberg, Thoraxklin, Zentrum Pulm Hypertonie, Heidelberg, Germany

[2] Herzzentrum Duisburg, Munich, Germany

[3] Klin Tech Univ Munchen, Deutsch Herzzentrum Munchen, Klin Kinderkardiol & Angeborene Herzfehler, Munich, Germany

[4] Hannover Med Sch, Klin Pneumol, Hannover, Germany

[5] Deutsch Zentrum Lungenforsch DZL, Giessen, Germany

[6] Univ Spital Zurich, Klin Pneumol, Zurich, Switzerland

[7] Herzzentrum Univ Klin Koln, Cologne, Germany

[8] Ludwig Maximilians Univ Munchen, Med Klin & Poliklin, Munich, Germany

[9] Klinikum St Georg, Klin Anasthesiol Intens & Schmerztherapie, Leipzig, Germany

[10] Univ Klin Carl Gustav Carus, Pneumol, Dresden, Germany

[11] Klinikum Konstanz, Med Klin 2, Constance, Germany

[12] Pulm Hypertonie eV, Rheinstetten, Germany

[13] Univ Klinikum Hamburg Eppendorf, Zentrum Pulm Arterielle Hypertonie Hamburg, Sekt Pneumol, Hamburg, Germany

来源：

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2016年 / 141卷

关键词：

general measures; supportive therapy; pulmonary arterial hypertension; QUALITY-OF-LIFE; CONGENITAL HEART-DISEASE; RIGHT ATRIAL-FLUTTER; IRON-DEFICIENCY; ANESTHETIC MANAGEMENT; EXERCISE CAPACITY; OXYGEN-THERAPY; PREGNANCY; OUTCOMES; PAH;

D O I：

10.1055/s-0042-114525

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The 2015 European Guidelines on Diagnosis and Treatment of Pulmonary Hypertension are also valid for Germany. The guidelines contain detailed recommendations for the targeted and supportive treatment of pulmonary arterial hypertension (PAH). However, the practical implementation of the European Guidelines in Germany requires the consideration of several country-specific issues and already existing novel data. This requires a detailed commentary to the guidelines, and in some aspects an update already appears necessary. In June 2016, a Consensus Conference organized by the PH working groups of the German Society of Cardiology (DGK), the German Society of Respiratory Medicine (DGP) and the German Society of Pediatric Cardiology (DGPK) was held in Cologne, Germany. This conference aimed to solve practical and controversial issues surrounding the implementation of the European Guidelines in Germany. To this end, a number of working groups was initiated, one of which was specifically dedicated to general and supportive therapy of PAH. This article summarizes the results and recommendations of this working group.

引用

页码：S26 / +

页数：9

共 50 条

[31] An Update on Medical Therapy for Pulmonary Arterial Hypertension
Yan Wu
Dermot S. O’Callaghan
Marc Humbert
[J]. Current Hypertension Reports, 2013, 15 : 614 - 622
[32] Inhaled iloprost for therapy in pulmonary arterial hypertension
Ewert, Ralf
Glaeser, Sven
Bollmann, Tom
Schaeper, Christoph
[J]. EXPERT REVIEW OF RESPIRATORY MEDICINE, 2011, 5 (02) : 145 - 152
[33] Advances in medical therapy for pulmonary arterial hypertension
Sisniega, Carlos
Zayas, Nayeli
Pulido, Tomas
[J]. CURRENT OPINION IN CARDIOLOGY, 2019, 34 (01) : 98 - 103
[34] Sildenafil citrate therapy for pulmonary arterial hypertension
Galiè, N
Ghofrani, HA
Torbicki, A
Barst, RJ
Rubin, LJ
Badesch, D
Fleming, T
Parpia, T
Burgess, G
Branzi, A
Grimminger, F
Kurzyna, M
Simonneau, G
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (20): : 2148 - 2157
[35] Continued Progress in Therapy for Pulmonary Arterial Hypertension
Taichman, Darren B.
Leopold, Jane A.
Elliott, Greg
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (16): : 1524 - 1526
[36] ECMO in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension as a bridge to therapy
Cruz-Utrilla, Alejandro
Martin, Elena Puerto Garcia
Perez, Laura Dominguez
Curiel, Anibal Ruiz
Quezada, Andres
Lopez, Alejandro Durante
Vicent, Lourdes
Asenjo, Roberto Martin
Hinojosa, Williams
Eixeres, Andrea
Acebal, Laura Forcen
Galindo, Maria
Ynsaurriaga, Fernando Arribas
Escribano-Subias, Pilar
Bueno, Hector
[J]. KARDIOLOGIA POLSKA, 2023, 81 (05) : 500 - 504
[37] Drug therapy: Treatment of pulmonary arterial hypertension
Humbert, M
Sitbon, O
Simonneau, G
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (14): : 1425 - 1436
[38] Pulmonary Arterial Hypertension: Combination Therapy in Practice
Marsha Burks
Simone Stickel
Nazzareno Galiè
[J]. American Journal of Cardiovascular Drugs, 2018, 18 : 249 - 257
[39] Targeted Therapy of pulmonary arterial Hypertension (PAH)
Klose, H.
Opitz, C.
Bremer, H.
Ewert, R.
Bonderman, D.
Rosenkranz, S.
Seeger, W.
Schmeisser, A.
Harbaum, L.
Buerke, M.
Ghofrani, H. Ardeschir
Borst, M. M.
Leuchte, H. H.
Lange, T. J.
Behr, J.
Ulrich, S.
Lang, I.
Olschewski, H.
Gall, H.
Kabitz, H. -J.
Kleber, F. -X.
Held, M.
Hoeper, M. M.
Gruenig, E.
[J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2014, 139 : S142 - S150
[40] Combination therapy in the management of pulmonary arterial hypertension
Buckley, M. S.
Staib, R. L.
Wicks, L. M.
[J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2013, 67 : 13 - 23

← 1 2 3 4 5 →